These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2104664

  • 1. Leukemia following chemotherapy for ovarian cancer.
    Kaldor JM, Day NE, Pettersson F, Clarke EA, Pedersen D, Mehnert W, Bell J, Høst H, Prior P, Karjalainen S.
    N Engl J Med; 1990 Jan 04; 322(1):1-6. PubMed ID: 2104664
    [Abstract] [Full Text] [Related]

  • 2. Leukemia following Hodgkin's disease.
    Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D.
    N Engl J Med; 1990 Jan 04; 322(1):7-13. PubMed ID: 2403650
    [Abstract] [Full Text] [Related]

  • 3. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
    Travis LB, Holowaty EJ, Bergfeldt K, Lynch CF, Kohler BA, Wiklund T, Curtis RE, Hall P, Andersson M, Pukkala E, Sturgeon J, Stovall M.
    N Engl J Med; 1999 Feb 04; 340(5):351-7. PubMed ID: 9929525
    [Abstract] [Full Text] [Related]

  • 4. Acute leukemia after alkylating-agent therapy of ovarian cancer.
    Reimer RR, Hoover R, Fraumeni JF, Young RC.
    N Engl J Med; 1977 Jul 28; 297(4):177-81. PubMed ID: 406560
    [Abstract] [Full Text] [Related]

  • 5. Risk of leukemia after chemotherapy and radiation treatment for breast cancer.
    Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN.
    N Engl J Med; 1992 Jun 25; 326(26):1745-51. PubMed ID: 1594016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Leukemia following chemotherapy for breast cancer.
    Curtis RE, Boice JD, Moloney WC, Ries LG, Flannery JT.
    Cancer Res; 1990 May 01; 50(9):2741-6. PubMed ID: 2328500
    [Abstract] [Full Text] [Related]

  • 10. A case-control study of leukaemia as a second primary malignancy following ovarian and breast neoplasms.
    Mehnert WH, Haas JF, Kittelmann B, Staneczek W, Möhner M, Kaldor JM, Day NE.
    IARC Sci Publ; 1986 May 01; (78):203-21. PubMed ID: 3583391
    [Abstract] [Full Text] [Related]

  • 11. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K.
    J Clin Oncol; 2003 Aug 15; 21(16):3066-71. PubMed ID: 12915595
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
    Weaver CH, Bensinger WI, Appelbaum FR, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):813-9. PubMed ID: 7889015
    [Abstract] [Full Text] [Related]

  • 13. High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
    Antman K, Ayash L, Elias A, Wheeler C, Schwartz G, Mazanet R, Tepler I, Schnipper LE, Frei E.
    J Natl Cancer Inst Monogr; 1994 Nov 15; (16):91-4. PubMed ID: 7528031
    [Abstract] [Full Text] [Related]

  • 14. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH, Boice JD, Greer BE, Blessing JA, Dembo AJ.
    N Engl J Med; 1982 Dec 02; 307(23):1416-21. PubMed ID: 6752720
    [Abstract] [Full Text] [Related]

  • 15. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.
    Clin Cancer Res; 1999 Nov 02; 5(11):3411-8. PubMed ID: 10589752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T, Vance R, Puneky L, Khansur T.
    Gynecol Oncol; 1994 Dec 02; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.